The Center of Excellence for Metabolic and Bariatric Surgery, Hospital Oswaldo Cruz, São Paulo, Brazil.
Obes Surg. 2013 Jun;23(6):809-18. doi: 10.1007/s11695-013-0930-2.
Bariatric surgery was developed with the aim of weight reduction. Success was defined only by excess weight loss. Other indices of resolution of metabolic comorbidities were reported, but were mostly secondary. Several communications have reported that regardless of body mass index (BMI), complete or partial remission of type 2 diabetes mellitus (T2DM) is possible. These results mostly occur before weight loss, positioning metabolic surgery as a good tool for controlling the current T2DM epidemic. Medical treatment is evolving, but is expensive and not risk-free. Surgery aimed mainly at diseases such as diabetes and not weight loss are referred to as "metabolic surgery." Metabolic surgery has been proven to be safe and effective, and although more data are needed, it is unquestionable that a new discipline has been founded. Metabolic surgery can effectively treat T2DM in individuals with any BMI, including that below 35 kg/m(2).
减重手术是为了减轻体重而发展起来的。成功仅被定义为超重的减轻。其他代谢合并症的解决指标也有报道，但大多是次要的。有几项报告称，无论体重指数（BMI）如何，都有可能完全或部分缓解 2 型糖尿病（T2DM）。这些结果主要发生在体重减轻之前，使代谢手术成为控制当前 T2DM 流行的一种良好工具。医学治疗在不断发展，但既昂贵又有风险。主要针对糖尿病等疾病而非体重减轻的手术被称为“代谢手术”。代谢手术已被证明是安全有效的，尽管还需要更多的数据，但毫无疑问，一个新的学科已经建立。代谢手术可以有效治疗任何 BMI 的个体的 T2DM，包括 BMI 低于 35kg/m(2)的个体。
